Related Experiment Video
Updated: Apr 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Negative regulation of TGFβ-induced lens epithelial to mesenchymal transition (EMT) by RTK antagonists
Guannan Zhao1, Magdalena C Wojciechowski1, Seonah Jee1
1Discipline of Anatomy and Histology, Bosch Institute, University of Sydney, NSW, Australia.
Abstract:
An eclectic range of ocular growth factors with differing actions are present within the aqueous and vitreous humors that bathe the lens. Growth factors that exert their actions via receptor tyrosine kinases (RTKs), such as FGF, play a normal regulatory role in lens; whereas other factors, such as TGFβ, can lead to an epithelial to mesenchymal transition (EMT) that underlies several forms of cataract. The respective downstream intracellular signaling pathways of these factors are in turn tightly regulated. One level of negative regulation is thought to be through RTK-antagonists, namely, Sprouty (Spry), Sef and Spred that are all expressed in the lens. In this study, we tested these different negative regulators and compared their ability to block TGFβ-induced EMT in rat lens epithelial cells. Spred expression within the rodent eye was confirmed using RT-PCR, western blotting and immunofluorescence. Rat lens epithelial explants were used to examine the morphological changes associated with TGFβ-induced EMT over 3 days of culture, as well as α-smooth muscle actin (α-sma) immunolabeling. Cells in lens epithelial explants were transfected with either a reporter (EGFP) vector (pLXSG), or with plasmids also coding for different RTK-antagonists (i.e. pLSXG-Spry1, pLSXG-Spry2, pLXSG-Sef, pLSXG-Spred1, pLSXG-Spred2, pLSXG-Spred3), before treating with TGFβ for up to 3 days. The percentages of transfected cells that underwent TGFβ-induced morphological changes consistent with an EMT were determined using cell counts and validated with a paired two-tailed t-test. Explants transfected with pLXSG demonstrated a distinct transition in cell morphology after TGFβ treatment, with ∼60% of the cells undergoing fibrotic-like cell elongation. This percentage was significantly reduced in cells overexpressing the different antagonists, indicative of a block in lens EMT. Of the antagonists tested under these in vitro conditions, Spred1 was the most potent demonstrating the greatest block in TGFβ-induced fibrotic cell elongation/EMT. Through the overexpression of RTK-antagonists in lens epithelial cells we have established a novel role for Spry, Spred and Sef as negative regulators of TGFβ-induced EMT. Further investigations may help us develop a better understanding of the molecular mechanisms involved in maintaining the integrity of the normal lens epithelium, with these antagonists serving as putative therapeutic agents for prevention of EMT, and hence cataractogenesis.
Insights
This study reveals that Spred1 is the most effective negative regulator, blocking transforming growth factor-beta (TGFβ)-induced epithelial to mesenchymal transition (EMT) in rat lens cells. These findings highlight potential therapeutic targets for preventing cataractogenesis.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Ocular growth factors regulate lens function, but some, like TGFβ, can induce epithelial to mesenchymal transition (EMT), a process implicated in cataract formation.
- Receptor tyrosine kinase (RTK) antagonists, including Sprouty (Spry), Sef, and Spred, are present in the lens and are thought to negatively regulate signaling pathways.
Purpose of the Study:
- To compare the efficacy of different RTK antagonists (Spry, Sef, Spred) in blocking TGFβ-induced EMT in rat lens epithelial cells.
- To investigate the role of Spry, Sef, and Spred as negative regulators of TGFβ-induced EMT in the lens.
Main Methods:
- Confirmed Spred expression in rodent eyes using RT-PCR, western blotting, and immunofluorescence.
- Cultured rat lens epithelial explants and induced EMT with TGFβ, assessing morphological changes and α-smooth muscle actin (α-sma) expression.
- Transfected explants with vectors expressing RTK antagonists or a control, followed by TGFβ treatment and cell counting to quantify EMT.
Main Results:
- TGFβ treatment induced EMT in approximately 60% of control-transfected lens epithelial cells, characterized by fibrotic-like cell elongation.
- Overexpression of Spry, Sef, and Spred significantly reduced the percentage of cells undergoing TGFβ-induced EMT.
- Spred1 demonstrated the most potent inhibitory effect on TGFβ-induced fibrotic cell elongation and EMT in vitro.
Conclusions:
- Spry, Spred, and Sef function as novel negative regulators of TGFβ-induced EMT in lens epithelial cells.
- Spred1 is identified as a particularly potent inhibitor of lens EMT.
- These RTK antagonists represent potential therapeutic agents for preventing EMT and cataractogenesis.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Regulation of Angiogenesis and Blood Supply